Immunoallergic drug-induced hepatitis: lessons from halothane

This publication has 35 references indexed in Scilit:

• Identification of the enzyme responsible for oxidative halothane metabolism: implications for prevention of halothane hepatitis
  The Lancet, 1996
• Human Cytochrome P450 2E1 Is a Major Autoantigen Associated with Halothane Hepatitis
  Chemical Research in Toxicology, 1996
• Immunopathogenesis and Treatment of Halothane Hepatitis
  Clinical Immunotherapeutics, 1995
• Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: A putative probe of CYP2E1 activity
  Clinical Pharmacology & Therapeutics, 1994
• Formation of trifluoroacetylated protein antigens in cultured rat hepatocytes exposed to halothane in vitro
  Biochemical Pharmacology, 1994
• The topography of trifluoroacetylated protein antigens in liver microsomal fractions from halothane treated rats
  Biochemical Pharmacology, 1992
• Evidence for expression in human liver of halothane-induced neoantigens recognized by antibodies in sera from patients with halothane hepatitis
  Hepatology, 1988
• Antibodies to the Surface of Halothane-Altered Rabbit Hepatocytes in Patients with Severe Halothane-Associated Hepatitis
  New England Journal of Medicine, 1980
• SENSITISATION TO HALOTHANE-ALTERED LIVER COMPONENTS IN SEVERE HEPATIC NECROSIS AFTER HALOTHANE ANqSTHESIA
  The Lancet, 1978
• Unexplained hepatitis following halothane.
  BMJ, 1976